About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Current Treatment of Familial Hypercholesterolaemia

Citation:

European Cardiology Review 2014;9(2):76–81

Antiplatelet and Lipid-lowering Drugs in Hypertension

Citation:

European Cardiology Review 2014;9(1):16–20

New Developments in Pulmonary Arterial Hypertension

Citation:

European Cardiovascular Disease 2006;2(1):1–6

Landscape of Combination Therapy - Which Way Forward? Proceedings of the Satellite Symposium Held at the ESH European Meeting on Hypertension and Cardiovascular Protection, 27 April 2012, London

Citation:

European Cardiology 2012;8(3):192–7